ALIMTA
information and resources from the National Cancer Institute
ALIMTA
(Other name for: pemetrexed disodium)Alkeran
(Other name for: melphalan)ALIMTA
(Other name for: pemetrexed disodium)
|
|
|
|
news articles
Fears Over Guidance on Cancer Treatment 01 Apr 2006
International News Service, Alimta, a drug which was developed by Newcastle University scientist Professor Hilary Calvert, has been hailed as the first drug to shrink tumours and prolong ...
Alimta® and Paraplatin® Effective and Well-Tolerated in ... Mar 22, 2006
Cancer Consultants (press release), According to an article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Alimta® (pemetrexed) and Paraplatin ...
Hana Biosciences Initiates Talotrexin Phase II Clinical Trials in ... Mar 31, 2006
Genetic Engineering News, ...of Talotrexin. One patient who previously failed pemetrexed (Alimta(R)) has received 7 cycles of Talotrexin therapy. Median duration ...
Millennium Pharmaceuticals: more Velcade ventures Mar 7, 2006
Pharmaceutical Business Review It aims to recruit 135 patients who will be randomized to receive either Velcade and pemetrexed (marketed as Alimta by Eli Lilly), Velcade alone or pemetrexed ...
Cancer Drug Hope Mar 3, 2006
International News Service, Fresh hope was given to lung cancer sufferers today as a leading figure said wonder drug Alimta can extend life longer than previously thought. ...
UPDATE 2-Sanofi's Taxotere wins backing for approval Mar 24, 2006
Reuters Branded rivals to Taxotere are Roche Holding's (ROG.VX: Quote, Profile, Research) Avastin and Eli Lilly and Co's (LLY.N: Quote, Profile, Research) Alimta. ...
Tomudex® Plus Platinol® and Platinol Alone Reduce Dyspnea in ... Mar 22, 2006
Cancer Consultants (press release), The anti-metabolite that has been studied the most is Alimta® (pemetrexed) which has been combined with Platinol producing results superior to Platinol alone. ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 24, 2006
Cancer Consultants (press release), Alimta® (pemetrexed) and Tomudex are two relatively new anti-folate agents that have demonstrated activity in pancreatic cancer in phase I and II trials. ...
Velcade Lung Cancer Study Begins Mar 6, 2006
TheStreet.com ...look at the safety and possible benefits of combining Velcade with the Eli Lilly (LLY:NYSE - commentary - research - Cramer's Take) drug Alimta in patients ...
FDA advisers reject Lilly cancer drug Mar 14, 2006
Trade Arabia, Another Lilly cancer drug on the market, Alimta, is close to final studies for the disease, while an agent known as enzastaurim is nearing preclinical trials ...
Lilly Launches Phase III Trial of Targeted Cancer Agent Mar 9, 2006
news aktuell (Pressemitteilung), Alimta(R) (pemetrexed, Eli Lilly and Company) Gemzar(R) (gemcitabine HCl, Eli Lilly and Company) CeeNU(R) (lomustine [CCNU], Bristol Myers Squibb) (Logo: http ...
Cancer linked to building materials affect many Dec 18, 2005
Xinhua, US-based Eli Lilly announced over the weekend that it has introduced Alimta, the world's first medication to treat the asbestos-related malign pleural ...
Lilly Says 2006 Earnings to Rise on New Drug Sales (Update1) Dec 9, 2005
Bloomberg ...are briefing investors on his strategy of expanding sales of newer products such as the depression drug Cymbalta and the cancer treatment Alimta as revenue ...
Lilly Raises 2006 Earnings Forecast by 63 Percent (Update2) Dec 9, 2005
Bloomberg Demand for the cancer treatment Alimta quadrupled in the first nine months this year, while the depression drug Cymbalta had a 13-fold sales jump. ...
Lung cancer drug 'gets go-ahead' Dec 9, 2005
BBC News, ...lung cancer drug. Regional health bosses have lifted restrictions on Alimta to be given to people with mesothelioma. The decision ...
Don Peasley Dec 17, 2005
Northwest Herald, His father points with pride to his son's success in discovering two drugs – Alimta and Gemzar – marketed by Eli Lilly and amounting to more than $1 ...
Sales Forecast Dec 9, 2005
Bloomberg Cymbalta sales in the first nine months of this year reached $450.9 million, while demand for Alimta climbed to $327.4 million. ...
Asbestos drug gets fast-track status Nov 19, 2005
The Japan Times, Under its priority system for drug evaluation, the ministry will shorten the review period on Alimta, also known as Pemetrexed, to one year, it said. ...
Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
PR Newswire (press release), Our commitment to continuous innovation in cancer care has resulted in enduring therapies such as Gemzar(R) and Alimta(R), which are already helping patients ...
Eli Lilly Set For Sales Growth Dec 1, 2005
Forbes Schott also expects Lilly to comment on the progress of additional indications for depression drug Cymbalta and cancer treatment Alimta. ...
Lilly sees profit topping Wall Street Dec 9, 2005
ABC News The other new drugs include Strattera for attention deficit disorder, Forteo for osteoporosis, Xigris for sepsis bloodstream infections, Alimta for cancer and ...
Analysts back Lilly's rosy forecast Dec 9, 2005
United Press International In addition to recent launches that include Byetta, Cymbalta and Alimta, Rauch said, further launches are expected in the coming years, including Arxxant for ...
Investigational Targeted Therapy May Offer Progress For Non ... Dec 10, 2005
news aktuell (Pressemitteilung), Gemzar(R) (gemcitabine, Eli Lilly and Company) Alimta(R) (pemetrexed, Eli Lilly and Company) (1)Lymphoma Research Foundation, "Learning About Lymphoma ...
Eli Lilly "buy" Dec 2, 2005
New Ratings The analyst expects Eli Lilly to provide updates on its Zyprexa, Cymbalta and Alimta drugs, and discuss the progress on prasugrel’s phase III programme. ...
SF Jury Finds Chrysotile Asbestos Causes Rare Peritoneal ... Nov 18, 2005
PR Web (press release), After over two years of treatment with chemotherapy, including Alimta®, his cancer is currently in a temporary state of remission. ...
|
|
